Characterization of sequence specificities and structures of QNEs
QNE 的序列特异性和结构表征
基本信息
- 批准号:7904630
- 负责人:
- 金额:$ 42.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvisory CommitteesAgreementAmino AcidsAntibodiesAntigensBindingBiochemicalBiological AssayCarbohydratesChimera organismCommunicationCrystallizationDNA Sequence RearrangementDependenceEpitopesFunding MechanismsGenetic Complementation TestGoalsHIV Envelope Protein gp120HIV-2Human ResourcesImmune SeraIndividualInstitutionIntellectual PropertyLearningLegalLocationMacaca mulattaMapsMasksMediationModelingMolecularMolecular CloningMolecular ConformationMonitorMonkeysMutationPreparationPropertyProteinsPublicationsReagentReportingResistanceScientistScreening procedureSerumSiteSite-Directed MutagenesisSon of Sevenless ProteinsSouth AfricaSpecificityStructureTestingU-Series Cooperative AgreementsUnited States National Institutes of HealthVertebral columnViralViral ProteinsWorkdisulfide bondenv Gene Productsimmunogenicitymembermutantneutralizing antibodynovelprogramsresearch studyscaffoldsimian human immunodeficiency virussimulationvector
项目摘要
The Administrative core will be responsible for the overall management of this HIVRAD. This Core will be
responsible for interacting with DAIDS Program Officer and Staff as required by the funding mechanism as a
multi-project cooperative agreement between our team and the NIH. The Core will coordinate all aspects of
routine program management on administrative, financial, and regulator issues. The Administrative Core will
also organize and interact with external advisors, and host annual external reviews.
This Core has the following four Specific Aims:
1- To coordinate the interactions a) among scientists from different institutions included in the current
program and b) between our team and Scientific Advisory Board members and NIH personnel regarding efficient implementation of the proposed plans and projects.
2- To oversee budgetary matters, including review and approval of subcontractual agreements, monitoring of monthly expenses and preparation of various reports.
3- To develop an Intellectual Property plan and provide logistical support for intellectual property filings and negotiations
4- To coordinate publications and presentations of results arising from these studies.
行政核心将负责此Hivrad的整体管理。这个核心将是
负责根据资金机制的要求与DAIDS计划官员和员工进行互动
我们团队与NIH之间的多项目合作协议。核心将协调
关于行政,财务和监管机构问题的常规计划管理。行政核心将
还与外部顾问组织和互动,并举办年度外部评论。
该核心具有以下四个特定目标:
1-协调相互作用a)当前包括不同机构的科学家之间
计划和b)我们的团队与科学顾问委员会成员与NIH人员之间有关拟议计划和项目的有效实施。
2-监督预算事项,包括审查和批准分包协议,监视每月费用以及准备各种报告。
3-制定知识产权计划并为知识产权申请和谈判提供后勤支持
4-协调这些研究引起的结果的出版物和结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ABRAHAM PINTER其他文献
ABRAHAM PINTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ABRAHAM PINTER', 18)}}的其他基金
Development of a highly-sensitive urine test for tuberculosis (TB) that detects diverse forms of urinary TB lipoarabinomannan (uLAM)
开发一种高灵敏度的结核病尿液检测方法,可检测多种形式的尿液结核菌脂阿拉伯甘露聚糖 (uLAM)
- 批准号:
10667871 - 财政年份:2022
- 资助金额:
$ 42.8万 - 项目类别:
Complementary diagnostic biomarkers of sputum culture-negative TB [R21]
痰培养阴性结核病的补充诊断生物标志物 [R21]
- 批准号:
10557869 - 财政年份:2022
- 资助金额:
$ 42.8万 - 项目类别:
Complementary diagnostic biomarkers of sputum culture-negative TB [R21]
痰培养阴性结核病的补充诊断生物标志物 [R21]
- 批准号:
10433028 - 财政年份:2022
- 资助金额:
$ 42.8万 - 项目类别:
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
基于尿形式阿拉伯脂甘露聚糖抗原的超灵敏检测,增强 HIV 感染儿童结核病的 POC 检测
- 批准号:
10611413 - 财政年份:2020
- 资助金额:
$ 42.8万 - 项目类别:
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
基于尿形式阿拉伯脂甘露聚糖抗原的超灵敏检测,增强 HIV 感染儿童结核病的 POC 检测
- 批准号:
10675836 - 财政年份:2020
- 资助金额:
$ 42.8万 - 项目类别:
Enhanced POC assay for TB in HIV-infected children based on the ultrasensitive detection of the urinary form of the lipoarabinomannan antigen
基于尿形式阿拉伯脂甘露聚糖抗原的超灵敏检测,增强 HIV 感染儿童结核病的 POC 检测
- 批准号:
10378761 - 财政年份:2020
- 资助金额:
$ 42.8万 - 项目类别:
Novel epitopes that mediate broad neutralization of clade B and C HIV-1 isolates
介导 B 型和 C 型 HIV-1 分离株广泛中和的新表位
- 批准号:
8701676 - 财政年份:2013
- 资助金额:
$ 42.8万 - 项目类别:
Optimizing protective vaccine targets in the V1/V2 domain of HIV-1 gp120
优化 HIV-1 gp120 V1/V2 结构域中的保护性疫苗靶标
- 批准号:
8501371 - 财政年份:2012
- 资助金额:
$ 42.8万 - 项目类别:
Optimizing protective vaccine targets in the V1/V2 domain of HIV-1 gp120
优化 HIV-1 gp120 V1/V2 结构域中的保护性疫苗靶标
- 批准号:
8410364 - 财政年份:2012
- 资助金额:
$ 42.8万 - 项目类别:
Strategies for Eliciting bnAbs against Conserved HIV-1 Quaternary Epitopes
引发针对保守的 HIV-1 四级表位的 bnAb 的策略
- 批准号:
8035414 - 财政年份:2010
- 资助金额:
$ 42.8万 - 项目类别:
相似海外基金
The development of a systematic approach to harness real-world evidence for the evaluation of medication safety and effectiveness in children
开发一种系统方法来利用现实世界的证据来评估儿童用药的安全性和有效性
- 批准号:
10739628 - 财政年份:2023
- 资助金额:
$ 42.8万 - 项目类别:
Assessment of a Radiomics-Based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules
基于放射组学的计算机辅助诊断工具对肺结节癌症风险分层的评估
- 批准号:
10644765 - 财政年份:2023
- 资助金额:
$ 42.8万 - 项目类别: